SARS-CoV-2 vaccination efficacy on hospitalisation and variants

Sacha Rozencwajg; Alice Blet; Antoine Lamer; Thomas Clavier; Osama Abou-Arab; Stéphanie Sigaut; Fanny Bounes; Arthur James; Denis Frasca; Matthieu Boisson; Anaïs Caillard; Aude Carillion; Marc-Olivier Fischer

doi:10.1016/j.accpm.2021.100874

SARS-CoV-2 vaccination efficacy on hospitalisation and variants

Anaesth Crit Care Pain Med. 2021 Jun;40(3):100874. doi: 10.1016/j.accpm.2021.100874. Epub 2021 May 1.

Authors

Affiliations

¹ AP-HP, Bichat University Hospital, DMU PARABOL, Department of Anaesthesiology and Critical Care, Paris, France; INSERM UMRS-1166, Institute of Cardiometabolism and Nutrition, Paris, France. Electronic address: sacha.rozencwajg@aphp.fr.
² Lariboisière-Saint-Louis Hospitals, Department of Anaesthesiology, Critical Care and Burn Centre, DMU Parabol, AP-HP Nord, University of Paris, Paris, France; University of Paris, Inserm UMR-S 942, Cardiovascular Markers in Stress Conditions (MASCOT), Paris, France; University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.
³ Univ. Lille, CHU Lille, ULR 2694 - METRICS: Evaluation des Technologies de santé et des Pratiques médicales, F-59000, Lille, France.
⁴ Department of Anaesthesiology, Critical Care and Perioperative Medicine, Rouen University Hospital, 1 rue de Germont, 76000 Rouen, France; Normandie Univ, UNIROUEN, Inserm U1096, EnVi, Rouen F-76000, France.
⁵ University of Amiens-Picardie, Departement of Anaesthesia and Critical Care, Amiens, France.
⁶ AP-HP, Beaujon University Hospital, DMU PARABOL, Department of Anaesthesiology and Critical Care, Clichy, France; Inserm U1141 NeuroDiderot, Robert Debré Hospital, Paris, France.
⁷ University Hospital of Toulouse, Anaesthesia, Critical Care & Perioperative Medicine, Toulouse, France; University of Toulouse III, INSERM U1297, Institute of Cardiovascular and Metabolic Diseases, Toulouse, France.
⁸ Sorbonne University, GRC 29, AP-HP, DMU DREAM, Department of Anaesthesiology and critical care, Pitié-Salpêtrière Hospital, Paris, France.
⁹ University Hospital of Poitiers, Anaesthesiology, Critical Care and Perioperative Medicine Department, Poitiers, France; INSERM UMR-1246, France.
¹⁰ University Hospital of Poitiers, Anaesthesiology, Critical Care and Perioperative Medicine Department, Poitiers, France; INSERM U1070, Pharmacology of Antimicrobial Agents, University of Poitiers, France.
¹¹ Centre Hospitalier Universitaire La Cavale Blanche Université de Bretagne Ouest, Departement of Anaesthesiology, Critical Care and Perioperative Medicine, Brest, France.
¹² Sorbonne University, GRC 29, AP-HP, DMU DREAM, Department of Anaesthesiology and critical care, Pitié-Salpêtrière Hospital, Paris, France; Normandie Univ, UNIROUEN, Inserm U1096, EnVi, Rouen F-76000, France.
¹³ Normandie Univ, UNICAEN, CHU de Caen Normandie, Service d'Anesthésie Réanimation, 14000 Caen, France.

Abstract

We report data regarding three countries with similar healthcare systems which had three different vaccinal strategies between 1st of January and 10th of April 2021: rapid full vaccination (Israel), rapid first-dose vaccination (United Kingdom) and a delayed vaccination strategy (France).

Publication types

Editorial

MeSH terms

Brazil
COVID-19 / prevention & control*
COVID-19 / virology
COVID-19 Vaccines / administration & dosage*
France
Hospitalization / statistics & numerical data*
Humans
Immunization Programs / methods
Immunization Programs / statistics & numerical data*
Immunization Schedule
Israel
SARS-CoV-2 / immunology
South Africa
United Kingdom

Substances

COVID-19 Vaccines